Lithium and valproate in bipolar disorder: from international evidence-based guidelines to clinical predictors C Crapanzano, I Casolaro, C Amendola, S Damiani Clinical Psychopharmacology and Neuroscience 20 (3), 403, 2022 | 13 | 2022 |
Quetiapine in the anxiety dimension of mood disorders: a systematic review of the literature to support clinical practice C Crapanzano, S Damiani, C Guiot Journal of Clinical Psychopharmacology 41 (4), 436-449, 2021 | 10 | 2021 |
Quetiapine treatment for post-traumatic stress disorder: a systematic review of the literature C Crapanzano, S Damiani, I Casolaro, C Amendola Clinical Psychopharmacology and Neuroscience 21 (1), 49, 2023 | 7 | 2023 |
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder M Ballerio, P Politi, C Crapanzano, E Emanuele, A Cuomo, A Goracci, ... Neuroendocrinology Letters 39 (3), 205-208, 2018 | 7 | 2018 |
Vortioxetine-induced nausea and its treatment: a case report C Crapanzano, A Politano, C Amendola, D Koukouna, I Casolaro Archives of Clinical Psychiatry (São Paulo) 47 (5), 160-161, 2020 | 5 | 2020 |
Olanzapine for the treatment of somatic symptom disorder: biobehavioral processes and clinical implications C Crapanzano, C Amendola, A Politano, PF Laurenzi, I Casolaro Psychosomatic Medicine 84 (3), 393-395, 2022 | 4 | 2022 |
Clinical perspective on antipsychotic receptor binding affinities C Crapanzano, PF Laurenzi, C Amendola, I Casolaro Brazilian Journal of Psychiatry 43 (6), 680-681, 2021 | 4 | 2021 |
Efficacy of olanzapine in anxiety dimension of schizophrenia: a systematic review of randomized controlled trials C Crapanzano, I Casolaro, S Damiani, C Amendola Clinical Psychopharmacology and Neuroscience 20 (4), 592, 2022 | 3 | 2022 |
Clothiapine: highlights on pharmacological and clinical profile of an undervalued drug C Crapanzano, C Amendola, C Conigliaro, I Casolaro Swiss Archives of Neurology, Psychiatry and Psychotherapy 173 (03), 2022 | 3 | 2022 |
Combining Aripiprazole and Haloperidol: Focus on D2 Receptor. C Crapanzano, PF Laurenzi, C Amendola, I Casolaro Journal of Clinical Pharmacology 62 (7), 2022 | 2 | 2022 |
Antipsychotic monotherapy in obsessive-compulsive disorder C Crapanzano, PF Laurenzi, I Casolaro, A Politano, C Amendola Psychiatria Danubina 34 (1), 106-106, 2022 | 2 | 2022 |
Intramuscular and intravenous trazodone for the treatment of agitation C Crapanzano, M Ballerio, S Bolognesi, A Goracci, A Fagiolini Eur Neuropsychopharmacol 29, S241, 2019 | 2 | 2019 |
Brexpiprazole 2 mg Starting Dose: A Case Series C Crapanzano, I Casolaro, B Beccarini Crescenzi, C Amendola Psychiatria Danubina 34 (2), 308-309, 2022 | 1 | 2022 |
Use of parenteral trazodone in bipolar disorder C Amendola, C Crapanzano, M Ballerio, S Bolognesi, A Goracci, ... European Neuropsychopharmacology 29, S91-S92, 2019 | 1 | 2019 |
Clozapine-induced sinus tachycardia in patients treated with a slow titration schedule G Amodeo, C Crapanzano, I Baldini, N Cipriani, L Del Matto, S Desantis, ... European Neuropsychopharmacology 26 (Supplement 2), S543-S544, 2016 | 1 | 2016 |
Lurasidone-induced Tardive Oromandibular Dystonia C Crapanzano, C Amendola, I Casolaro Swiss Archives of Neurology, Psychiatry and Psychotherapy, 2024 | | 2024 |
Off-label Use of Valproate in Anxiety Disorders C Crapanzano, I Casolaro, C Amendola, A Politano Swiss Archives of Neurology, Psychiatry and Psychotherapy, 2024 | | 2024 |
Prescription Patterns of Intramuscular Medication for Psychomotor Agitation: A Survey of Italian Psychiatrists C Crapanzano, N Redaelli, A Politano, I Casolaro, C Amendola Clinical Psychopharmacology and Neuroscience 22 (2), 376, 2024 | | 2024 |
Doświadczenia kliniczne z trazodonem stosowanym drogą pozajelitową w zaburzeniach nastroju: przegląd literatury. C Crapanzano, I Casolaro, AJ Krupa Psychiatria Polska 58 (3), 2024 | | 2024 |
Case report of lurasidone in the treatment of chronic tic disorders C Crapanzano, C Amendola, J Steen, I Casolaro Annals of clinical psychiatry: official journal of the American Academy of …, 2023 | | 2023 |